Eminence Biotechnology

China-based Eminence Biotechnology (Suzhou) Co., Ltd. has announced the full operation of its state-of-the-art cell culture media facility, which will cater to the production of vaccines, gene therapies, cell therapies, antibodies, and recombinant proteins. The new facility, located at the BIOBAY Phase II in Suzhou Industrial Park, spans approximately 7,000…